Randomized phase II study of abiraterone acetate maintenance in combination with docetaxel after disease progression to abiraterone acetate in metastatic castration-resistant prostate cancer (mCRPC): ABIDO SOGUG trial

Date issued
2014Journal title
Journal Of Clinical Oncology
Type of content
Publicación de congreso
